Paper41324820
CTC cluster in breast cancer: synergetic metastasis promotion mechanism and transformation path from platelet cloaking to leukocyte escort.
Guan C and 3 others. Clin Transl Oncol, 2026. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. CTC cluster in breast cancer: synergetic metastasis promotion mechanism and transformation path from platelet cloaking to leukocyte escort. Papers, record 41324820. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41324820
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- CTC cluster in breast cancer: synergetic metastasis promotion mechanism and transformation path from platelet cloaking to leukocyte escort.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Breast Neoplasms | Major topic |
| Neoplastic Cells, Circulating | Major topic |
| Blood Platelets | Major topic |
| Leukocytes | Major topic |
| Humans | |
| Female | |
| Neoplasm Metastasis | |
| Tumor Microenvironment |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 20232ACB206053 | Natural Science Foundation of Jiangxi Province | PubMed | ||
| 20203BBCL73205 | Key Research and Development Program of Jiangxi Province | PubMed |
Source PubMed
References72
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 40457073 | Phylogenetic inference reveals clonal heterogeneity in circulating tumor cell clusters. | Nat Genet | 2025 | https://conductscience.org/library/papers/40457073 | PubMed |
| 2 | 25367817 | Antitumor properties of a new non-anticoagulant heparin analog from the mollusk Nodipecten nodosus: Effect on P-selectin, heparanase, metastasis and cellular recruitment. | Glycobiology | 2015 | https://conductscience.org/library/papers/25367817 | PubMed |
| 3 | 21512161 | Evidence of platelet activation at medically used hypothermia and mechanistic data indicating ADP as a key mediator and therapeutic target. | Arterioscler Thromb Vasc Biol | 2011 | https://conductscience.org/library/papers/21512161 | PubMed |
| 4 | 33473163 | Clinical utility of circulating tumour cell-based monitoring of late-line chemotherapy for metastatic breast cancer: the randomised CirCe01 trial. | Br J Cancer | 2021 | https://conductscience.org/library/papers/33473163 | PubMed |
| 5 | 35455989 | Selectin-Mediated Signaling-Shedding Light on the Regulation of Integrin Activity in Neutrophils. | Cells | 2022 | https://conductscience.org/library/papers/35455989 | PubMed |
| 6 | 22591372 | Circulating tumour cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transition. | BMC Cancer | 2012 | https://conductscience.org/library/papers/22591372 | PubMed |
| 7 | 34072844 | Circulating Tumor Cells from Enumeration to Analysis: Current Challenges and Future Opportunities. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34072844 | PubMed |
| 8 | 31101536 | Partners in Crime: Neutrophil-CTC Collusion in Metastasis. | Trends Immunol | 2019 | https://conductscience.org/library/papers/31101536 | PubMed |
| 9 | 37770941 | The critical role of platelet in cancer progression and metastasis. | Eur J Med Res | 2023 | https://conductscience.org/library/papers/37770941 | PubMed |
| 10 | 28956830 | Platelet Integrins in Tumor Metastasis: Do They Represent a Therapeutic Target? | Cancers (Basel) | 2017 | https://conductscience.org/library/papers/28956830 | PubMed |
| 11 | 29884204 | Longitudinal enumeration and cluster evaluation of circulating tumor cells improve prognostication for patients with newly diagnosed metastatic breast cancer in a prospective observational trial. | Breast Cancer Res | 2018 | https://conductscience.org/library/papers/29884204 | PubMed |
| 12 | 25171411 | Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis. | Cell | 2014 | https://conductscience.org/library/papers/25171411 | PubMed |
| 13 | 24942131 | Living in shear: platelets protect cancer cells from shear induced damage. | Clin Exp Metastasis | 2014 | https://conductscience.org/library/papers/24942131 | PubMed |
| 14 | 12029005 | Evaluation of the anticoagulants EDTA and citrate, theophylline, adenosine, and dipyridamole (CTAD) for assessing platelet activation on the ADVIA 120 hematology system. | Clin Chem | 2002 | https://conductscience.org/library/papers/12029005 | PubMed |
| 15 | 25984697 | A microfluidic device for label-free, physical capture of circulating tumor cell clusters. | Nat Methods | 2015 | https://conductscience.org/library/papers/25984697 | PubMed |
| 16 | 31358544 | Circulating Tumor Cell Clusters in Patients with Metastatic Breast Cancer: a SWOG S0500 Translational Medicine Study. | Clin Cancer Res | 2019 | https://conductscience.org/library/papers/31358544 | PubMed |
| 17 | 33391283 | Alternative Pathways of IL-1 Activation, and Its Role in Health and Disease. | Front Immunol | 2020 | https://conductscience.org/library/papers/33391283 | PubMed |
| 18 | 22014578 | Macrophage binding to receptor VCAM-1 transmits survival signals in breast cancer cells that invade the lungs. | Cancer Cell | 2011 | https://conductscience.org/library/papers/22014578 | PubMed |
| 19 | 22102277 | Engagement of αIIbβ3 (GPIIb/IIIa) with ανβ3 integrin mediates interaction of melanoma cells with platelets: a connection to hematogenous metastasis. | J Biol Chem | 2012 | https://conductscience.org/library/papers/22102277 | PubMed |
| 20 | 35697674 | High throughput, label-free isolation of circulating tumor cell clusters in meshed microwells. | Nat Commun | 2022 | https://conductscience.org/library/papers/35697674 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42771114 | A Meta-Analysis of Deep-Learning-Based Fusion of Positron Emission Tomography and Computed Tomography in Oncologic Imaging. | J Imaging Inform Med | 2026 | https://conductscience.org/library/papers/42771114 | PubMed |
| 42039449 | Loss of Mast cells and histaminergic signaling link diet to platelet-mediated NETosis and mammary cancer recurrence. | bioRxiv | 2026 | https://conductscience.org/library/papers/42039449 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| FGB | 2244 | PubTator's text mining | https://conductscience.org/library/genes/2244 | NCBI Gene |
| SELP | 6403 | PubTator's text mining | https://conductscience.org/library/genes/6403 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41324820
GET https://conductscience.org/api/papers/v1/41324820/references?page=2